Haemonetics Corporation with ticker code (HAE) now have 7 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 115 and 90 calculating the average target price we see $105.29. Given that the stocks previous close was at $83.47 and the analysts are correct then we can expect a percentage increase in value of 26.1%. There is a 50 day moving average of $82.49 and the 200 day MA is $80.18. The company has a market capitalization of 4.17B. The current stock price for Targa Resources Corp. is currently 82.67 USD
The potential market cap would be $5,260,709,106 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 37.24, revenue per share of 23.01 and a 5.35% return on assets.
Haemonetics Corporation is a healthcare company. The Company provides a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Its segments include Plasma, Blood Center and Hospital. Its Plasma segment offers automated plasma collection and donor management software systems that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers’ ability to acquire blood, filter blood and separate blood components. Its Hospital segment provides the patient care. It markets and sells its products to biopharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations and national health organizations.
